검색결과 : 18건
No. | Article |
---|---|
1 |
BCR-ABL tyrosine kinase inhibition induces metabolic vulnerability by preventing the integrated stress response in K562 cells Kato Y, Kunimasa K, Sugimoto Y, Tomida A Biochemical and Biophysical Research Communications, 504(4), 721, 2018 |
2 |
Direct and rapid identification of T315I-Mutated BCR-ABL expressing leukemic cells using infrared microspectroscopy Sandt C, Feraud O, Bonnet ML, Desterke C, Khedhir R, Flamant S, Bailey CG, Rasko JEJ, Dumas P, Bennaceur-Griscelli A, Turhan AG Biochemical and Biophysical Research Communications, 503(3), 1861, 2018 |
3 |
MicroRNA-7 inhibits cell proliferation of chronic myeloid leukemia and sensitizes it to imatinib in vitro Jiang MJ, Dai JJ, Gu DN, Huang Q, Tian L Biochemical and Biophysical Research Communications, 494(1-2), 372, 2017 |
4 |
Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function Xiao MF, Ai HM, Li T, Rajoria P, Shahu P, Li XS Biochemical and Biophysical Research Communications, 472(4), 610, 2016 |
5 |
Application of Fe3O4 nanoparticles functionalized carbon nanotubes for electrochemical sensing of DNA hybridization Zhang W Journal of Applied Electrochemistry, 46(5), 559, 2016 |
6 |
Adiponectin signals through Adiponectin Receptor 1 to reverse imatinib resistance in K562 human chronic myeloid leukemia cells Wu SH, Zheng CP, Chen SY, Lin BJ, Chen YM, Zhou WJ, Li ZY Biochemical and Biophysical Research Communications, 456(1), 367, 2015 |
7 |
CCR7 is involved in BCR-ABL/STAP-2-mediated cell growth in hematopoietic Ba/F3 cells Kubo K, Iwakami M, Muromoto R, Inagaki T, Kitai Y, Kon S, Sekine Y, Oritani K, Matsuda T Biochemical and Biophysical Research Communications, 463(4), 825, 2015 |
8 |
Tyrosine kinase inhibitor Thiotanib targets Bcr-Abl and induces apoptosis and autophagy in human chronic myeloid leukemia cells Fan JJ, Dong XC, Zhang WX, Zeng X, Li YB, Sun Y, Wang SF, Wang ZY, Gao HJ, Zhao WL, Ju DW Applied Microbiology and Biotechnology, 98(23), 9763, 2014 |
9 |
Co-Encapsulation of Anti-BCR-ABL siRNA and Imatinib Mesylate in Transferrin Receptor-Targeted Sterically Stabilized Liposomes for Chronic Myeloid Leukemia Treatment Mendonca LS, Moreira JN, de Lima MCP, Simoes S Biotechnology and Bioengineering, 107(5), 884, 2010 |
10 |
Cloning, expression, purification and functional characterization of the oligomerization domain of Bcr-Abl oncoprotein fused to the cytoplasmic transduction peptide Huang SF, Liu DB, Zeng JM, Xiao Q, Luo M, Zhang WP, Tao K, Wen JP, Huang ZG, Feng WL Protein Expression and Purification, 64(2), 167, 2009 |